TRENDSPOTTER

Due to the events at the World Trade Center and the Pentagon last week, TRENDSPOTTER will not be appearing today. The column, which runs every Friday, will resume its normal publication schedule on Sept. 28. Ira Leiderman, managing partner of the Palladin Group, will bring readers up to date on how the current global financial climate might affect the genomics industry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.